LOBE Share Price Performance
Recent LOBE News & Updates
No updates
Lobe Sciences Ltd. Key Details
Last Reported Earnings
Feb 28, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.025
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -57.5%
Lobe Sciences Ltd. Competitors
About LOBE
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada.
Canadian Market Performance
- 7 Days: -0.5%
- 3 Months: 10.1%
- 1 Year: 15.6%
- Year to Date: 10.0%
Over the last 7 days, the market has remained flat, although notably the Materials sector declined by 4.2%. More promisingly, the market is up 16% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading